Eric Zudak, CEO of Thalocan Research Innovations, discusses Thalocan’s role in helping to address unmet needs in the immunodermatology area. With many, if not most inflammatory skin diseases being more common in Skin of Color than in lighter pigmented skin – Thalocan is proud to provide cutting edge technology, training and tools for more accurate scientific…
DetailsIn recognition of Hidradenitis Suppurativa Awareness week, Thalocan Research Innovations is proud to present our full conversation with Portia Combow, who graciously shares her story about living with HS for nearly twenty years. The generosity of people like Portia not only recognizes all of those who cope with this disease, but serves to inform many…
DetailsThank you all for the incredible response to our recent webinar! For those of you unable to attend live, click the link below: Watch the Webinar
DetailsView Thalocan CEO Eric Zudak’s presentation to the New York SOCRA Chapter examining the challenges with endpoints as it relates to enrollment diversity in dermatology trials. View Webinar
Details
